Start exploring your own markets for free

🚀 Try for Free

AI Therapeutics

Light Search completed

Invite

Radar Tracking

Subspaces (4)

Drug Discovery Optimization

Biomarker Identification

Genomic Data Analysis

Drug Repurposing

Pending to review

Not sure yet

Interested

Not interested

Download list

Showing 104 results

Company	Fit assessment	Description	Subspaces	Tags	HQ Location	Founding Date	Employees	Total Funding Raised	Last Funding Event	Received on
Genome Biologics	Genome Biologics effectively leverages machine learning for drug development, pattern discovery, and the expansion of novel therapeutics, including drug repurposing.	Operator of a Biotherapeutics platform intended to facilitate efficient and ethical drug development and positioning. The company's platform leverages the power of AI-based machine learning with a transformative single-cell in vitro and in vivo transgenesis to identify new compounds or to repurpose known compounds for the treatment of cardiovascular and cardiometabolic and cancer, enabling medical researchers to reduce the cost, time and ethical burden of preclinical research.	Drug Repurposing	Light Search	Germany	2016	5	$20.20M	Venture - Series Unknown, $17.33M, October 6, 2021	Oct 14, 2024
Sonrai Analytics	Sonrai Analytics effectively utilizes machine learning to discover new patterns and expand therapeutic options, supporting drug repurposing initiatives.	Developer of analytics software designed to elevate data, discover new treatments, or expedite research development. The company's software integrates multi-omic data, advanced AI analytics, and a secure infrastructure for accelerated drug candidate identification and biomarker discovery, enabling precision medicine organizations to streamline research, reduce time-to-market, and improve patient outcomes.	Drug Repurposing Biomarker Identification	Light Search	Belfast (United Kingdom)	2018	11 - 50	$3.48M	Venture - Series Unknown, November 10, 2022	Oct 14, 2024
Purposeful	Purposeful effectively leverages machine learning and pattern discovery to expand therapeutics through drug repurposing, maximizing the potential of existing drugs.	Provider of computational drug repurposing and bioinformatics services intended to discover alternative uses for existing drugs. The company's services help in identifying novel relationships in chemical and biological data, finding signals in structural data, omics, and pathway data processing, enabling doctors and medical professionals to provide necessary healthcare treatments in a cost-effective manner.	Drug Repurposing	Light Search	Greece	2018	7	$200.00K	Pre-Seed, $200.00K, October 18, 2018	Oct 14, 2024
Chemotargets	Chemotargets leverages machine learning for drug discovery, actively discovers patterns in drug safety, and expands therapeutic applications through drug repositioning.	Operator of a computationally-oriented biotech company intended to focus on the discovery of small molecule pharmaceuticals and cosmeceuticals. The company offers validated computational methodologies with predictive performance to fast-forward the process of bringing new products to market, enabling the pharmaceutical and cosmetics industry to speed up discovery and development programs apart from making them more cost-efficient.	Drug Repurposing	Light Search	Barcelona (Spain)	2006	11 - 50		NA	Oct 14, 2024
Galactica Biotech	Galactica Biotech effectively leverages machine learning and advanced analytical methods to discover new therapeutic applications for existing drugs, fulfilling all specified requirements.	Operator of a drug development platform intended to set new standards in the pharmaceutical industry adding value to drugs. The company's system utilizes advanced analytical methods including AI and ML to identify new uses for molecules and provides a drug-repurposing method to identify novel applications for molecules in the market and in the development of major and orphan diseases, enabling patients to reduce risk and companies to save time and cost.	Drug Discovery Optimization Drug Repurposing	Light Search	Ireland	2014	1 - 10		Seed, June 7, 2017	Oct 14, 2024
GATC Health	GATC Health effectively leverages machine learning to discover health patterns and expand therapeutics, while also utilizing its platform for potential drug repurposing.	Developer of a multi-omic advanced technology platform designed to provide insight into individualized, specific health risks. The company's platform offers personalized medical analysis and reporting for disease risk, tolerance, complications, and prevention, pre-screening clinical trial participants for predictive and medical professionals with individualized multi-omic data analyses outcomes and anomalies and whole-genome analysis, enabling individuals, clinicians, and corporations to greatly reduce or mitigate health and reduces the risk, time and costs for life sciences companies.	Drug Repurposing	Light Search	United States	2020	11 - 50	$5.41M	Seed, $240.00K, August 23, 2023	Oct 14, 2024
OPTIC	The company effectively leverages machine learning to enhance drug discovery, identify novel candidates, and discover new patterns in molecular activity.	Developer of AI technology designed to accelerate the process of molecular discovery. The company uses a unique approach based on molecular activity, allowing for the identification of potential drug compounds with high precision and speed, it also enhances the accuracy of drug compound discovery by using machine learning algorithms, helping pharma companies in drug discovery.	Drug Discovery Optimization	Light Search	San Francisco (United States)	2006	11 - 50	$11.00M	Seed, $11.00M, July 20, 2022	Oct 14, 2024
BioXcel	BioXcel Corporation effectively utilizes machine learning and AI technologies to expand therapeutics and discover new patterns, while also engaging in drug repurposing initiatives.	Operator of a biopharmaceutical firm intended to improve the clinical and regulatory success of drug development. The company utilizes artificial intelligence and big data analytics to advance the wave of medicines by developing medicines in immuno-oncology, neuroscience and rare diseases with high unmet needs, enabling clients to impact pharma productivity and innovation to benefit the entire healthcare ecosystem.	Drug Repurposing	Light Search	United States	2005	51 - 200		NA	Oct 14, 2024
Formation Bio	Formation Bio effectively leverages machine learning and innovative technologies to expand therapeutic options and repurpose existing drugs, enhancing the drug development process.	Developer of a biotech platform designed to bring treatments to patients by re-imagining drug development. The company's platform has scaled a network of trial sites to create clinical trial sites within the existing practices using a roaming cohort of certified research coordinators, optimized by software, data, and technology, enabling researchers to expand their access to human subjects for research studies, paid clinical trials, psychological research, and focus groups.	Drug Repurposing	Light Search	United States	2013	51 - 200	$528.00M	Series D, $372.00M, June 26, 2024	Oct 14, 2024
Recursion Pharmaceuticals	Recursion leverages machine learning to discover new biological patterns and expand therapeutic options, including drug repurposing.	Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.	Drug Repurposing	Light Search	United States	2013	501 - 1000	$3.78B	Post-IPO Equity, $200.00M, June 26, 2024	Oct 14, 2024